Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: A pilot study

Toxicology

Volumn 208, Issue 1, 2005, Pages 63-72

  Lavergne, Sidonie N ^a   Volkman, Erin M ^a   Maki, Jennifer E ^a   Yoder, Andrea R ^a   Trepanier, Lauren A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Ascorbate; Cysteine; Drug adducts; Drug allergy; Drug hypersensitivity; Glutathione; Hemoglobin

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SULFAMETHOXAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CYTOTOXICITY; DOG; DRUG HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNOGENICITY; LEUKOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBODY FORMATION; ASCORBIC ACID; BIOTRANSFORMATION; CYSTEINE; DOGS; DRUG HYPERSENSITIVITY; FEMALE; GLUTATHIONE; PILOT PROJECTS; RANDOM ALLOCATION; SPLEEN; SULFAMETHOXAZOLE;

CANIS FAMILIARIS; RODENTIA;

EID: 12444273307     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2004.11.009     Document Type: Article

References (44)

1. M. Britschgi, S. von Greyerz, C. Burkhart, and W. Pichler Molecular aspects of drug recognition by specific T cells Curr. Drug Targets 4 2003 1 11
2. A. Carr, A.S. Gross, J.M. Hoskins, R. Penny, and D.A. Cooper Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients AIDS 8 1994 333 337
3. A. Carr, B. Tindall, R. Penny, and D.A. Cooper In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV Clin. Exp. Immunol. 94 1993 21 25
4. G. Choquet-Kastylevsky, N. Santolaria, R. Tedone, M. Aujoulet, and J. Descotes Induction of delayed type hypersensitivity to sulfamethoxazole in mice: role of metabolites Tox Lett. 119 2001 183 192
5. A. Cribb, M. Miller, A. Tesoro, and S. Spielberg Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs Mol. Pharmacol. 38 1990 744 751
6. A. Cribb, C. Nuss, D. Alberts, D. Lamphere, D. Grant, S. Grossman, and S. Spielberg Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection Chem. Res. Toxicol. 9 1996 500 507
7. A.E. Cribb, B.L. Lee, L.A. Trepanier, and S.P. Spielberg Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis Adv. Drug React. Toxicol. Rev. 15 1996 9 50
8. A.E. Cribb, M. Miller, J.S. Leeder, J. Hill, and S.P. Spielberg Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione: implications for idiosyncratic toxicity Drug Metab. Disp. 19 1991 900 906
9. A.E. Cribb, L.R. Pohl, S.P. Spielberg, and J.S. Leeder Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum proteins J. Pharmacol. Exp. Ther. 282 1997 1064 1072
10. A.E. Cribb, and S.P. Spielberg An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogs Vet. Res. Commun. 14 1990 241 252
11. A.E. Cribb, S.P. Spielberg, and G.P. Griffin N-4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes Drug Metab. Disp. 23 1995 406 414
12. M.P. Daftarian, L.G. Filion, W. Cameron, B. Conway, R. Roy, F. Tropper, and F. Diaz-Mitoma Immune response to sulfamethoxazole in patients with AIDS Clin. Diag. Lab. Immunol. 2 1995 199 204
13. P. Eyer, E. Lierheimer, and M. Schneller Reactions of nitroschloramphenicol in blood Biochem. Pharmacol. 33 1984 2299 2308
14. H.J. Gill, S.J. Hough, D.J. Naisbitt, J.L. Maggs, N.R. Kitteringham, M. Pirmohamed, and B.K. Park The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat J. Pharmacol. Exp. Ther. 282 1997 795 801
15. F.M. Gordin, G.L. Simon, C.B. Wofsy, and J. Mills Adverse reactions to trimethoprim-sulfamethoxazole in patients with AIDS Ann. Int. Med. 100 1984 495 499
16. R. Gruchalla, R. Pesenko, T. Do, and D. Skiest Sulfonamide-induced reactions in desensitized patients with AIDS- the role of covalent protein haptenation by sulfamethoxazole J. Aller. Clin. Immunol. 101 1998 371 378
17. J. Kovacs, and H. Masur Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection N. Engl. J. Med. 342 2000 1416 1429
18. R. Kreisberg We blew it NEJM 332 1995 945 949
19. 5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J. Pharmacol. Exp. Ther. Aug 9.
20. B.I. Lee, I. Medina, N.L. Benowitz, P. Jacob, C.B. Wolfsy, and J. Mills Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis carinii pneumonia in patients with AIDS Ann. Int. Med. 110 1989 606 611
21. T. Manchada, D. Hess, L. Dale, S. Ferguson, and M. Rieder Haptenation of sulfonamide reactive metabolites to cellular proteins Mol. Pharm. 62 2002 1011 1026
22. D. Naisbitt, J. Farrell, S. Gordon, J. Maggs, C. Burkhart, W. Pichler, M. Pirmohamed, and B. Park Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation Mol. Pharm. 62 2002 628 637
23. D. Naisbitt, S. Gordon, M. Pirmohamed, C. Burkhart, A. Cribb, W. Pichler, and B. Park Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo Br. J. Pharmacol. 133 2001 295 305
24. D. Naisbitt, P. O'Neill, M. Pirmohamed, and B. Park Synthesis and reactions of nitroso sulfamethoxazole with biological nucleophiles: implication for immune mediated toxicity Bioorg. Med. Chem. Lett. 6 1996 1511 1516
25. D. Naisbitt, F. Vilar, A. Stalford, E. Wilkins, M. Pirmohamed, and B. Park Plasma cysteine deficiency and decreased reduction of nitroso sulfamethoxazole with HIV infection AIDS Res. Hum. Retrovir. 16 2000 1929 1938
26. D.J. Naisbitt, S.J. Hough, H.J. Gill, M. Pirmohamed, N.R. Kitteringham, and B.K. Park Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity Br. J. Pharmacol. 126 1999 1393 1407
27. A. Nassif, A. Bensussan, G. Dorothee, F. Mami-Chouaib, N. Bachot, M. Bagot, L. Boumsell, and J.-C. Roujeau Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis J. Invest. Dermatol. 118 2002 728 733
28. K. Okonjo, and I. Adejoro Hemoglobins with multiple reactive sulphydryl groups: the reaction of dog hemoglobin with 5,5′-dithiobis (2-nitrobenzoate) J. Protein Chem. 12 1993 33 37
29. U. Paniker, and N. Levine Dapsone and sulfapyridine Dermatol. Clin. 19 2001 79 86 viii
30. P. Pertel, and R. Hirschtick Adverse reactions to dapsone in persons infected with human immunodeficiency virus Clin. Infect. Dis. 18 1994 630 632
31. D. Plumb Veterinary Drug Handbook 2002 Iowa State University Press Ames
32. M.J. Rieder, R. Krause, and I.A. Bird Time-course of toxicity of reactive sulfonamide metabolites Toxicology 95 1995 141 146
33. M.J. Rieder, J. Uetrecht, N.H. Shear, M. Cannon, M. Miller, and S.P. Spielberg Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites Ann. Int. Med. 110 1989 286 289
34. M.J. Rieder, J. Uetrecht, N.H. Shear, and S.P. Spielberg Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides J. Pharmacol. Exp. Ther. 244 1988 724 728
35. M. Rodriguez, C. Sifri, and J. Fishman Failure of low-dose atovaquone prophylaxis against Pneumocystis jiroveci infection in transplant recipients Clin. Infect. Dis. 38 2004 e76 e78
36. N.H. Shear, S.P. Spielberg, D.M. Grant, B.K. Tang, and W. Kalow Differences in metabolism of sulfonamides predisposes to idiosyncratic toxicity Ann. Int. Med. 105 1986 179 184
37. R. Taraszewski, R. Harvey, and P. Rosman Death from drug-induced hemolytic anemia Postgrad. Med. 85 1989 79-80, 84
38. L. Trepanier Idiosyncratic toxicity associated with potentiated sulfonamides in the dog J. Vet. Pharmacol. Ther. 27 2004 129 138
39. L. Trepanier, A. Cribb, R. Danhof, and J. Toll Clinical and immunological findings in 45 dogs with sulfonamide-associated hypersensitivity (abstr.) J. Vet. Int. Med. 16 2002 363
40. L. Trepanier, R. Danhof, J. Toll, and D. Watrous Clinical findings in 40 dogs with hypersensitivity associated with administration of potentiated sulfonamides J. Vet. Int. Med. 17 2003 647 652
41. L. Trepanier, A. Yoder, S. Bajad, M. Beckwith, J. Bellehumeur, and F. Graziano Plasma ascorbate deficiency is associated with impaired reduction of nitroso sulfamethoxazole in HIV infection J. Acq. Immun. Def. Syndr. 36 2004 1041 1050
42. L.A. Trepanier, K. Ray, N. Winand, S.P. Spielberg, and A.E. Cribb Cytosolic arylamine N-acetyltransferase deficiency in the dog and other canids due to an absence of NAT genes Biochem. Pharmacol. 54 1997 73 80
43. A.J.A.M. Van der Ven, M.A. Mantel, T.B. Vree, P.P. Koopmans, and J.W.M. Van der Meer Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole Br. J. Clin. Pharmacol. 38 1994 147 150
44. S.L. Walmsley, S. Khorasheh, J. Singer, and O. Djurdjev A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057) J. Acq. Immun. Def. Syndr. Hum. Retrovirol. 19 1998 498 505